Hyloris

Developer of drugs for rare and orphan disease conditions

placeMinneapolis, Minnesota, United States calendar_todayFounded 2014 groups14 employees language hyloris.com

Registered entities

Social engagement

Social engagement: 10.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Noshaq, Saffelberg Investments, Nomainvest.

Investor typeCountShare
Venture capital125%
Private equity250%
Angel & family office125%

Recent activity

20 May 2026
Expansion
LégiaPark, Liège
12 May 2026
Event
euroPLX 91
8 May 2026
Event
Annual General Shareholders' Meeting
Coming soon